Register for An Optimal Model of Care for NASH Webinar

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Multidisciplinary Approach: An Optimal Model of Care for NASH. Endocrinologist Dr. Kenneth Cusi and hepatologist Dr. Mazen Noureddin join forces to shine a light on the emerging fatty liver disease epidemic, and what it will take to overcome this health burden. […]

Visit VelacurTM at Advancing GI Patient Care 2021

On July 24, find out how you can improve patient care for those with chronic liver disease at Advancing GI Patient Care 2021, an educational conference hosted by GI Alliance. Visit our in-person booth for live demos of VelacurTM, the first handheld 3D liver health assessment solution. Advancing GI Patient Care 2021 will deliver focused, […]

Register for The Future of GI Webinar

Sonic Incytes is pleased to host the live educational webinar, Scope Forward: The Future of GI is Now in Your Hands. Join entrepreneur and healthcare futurist Praveen Suthrum and gastroenterologist Dr. Bradley Sklar to discover insights and practical advice for the industry to thrive, not just survive in the coming decade. Key points to be […]

Live Webinar: Advances in NASH Drugs & The Role of NITs

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Advances in NASH Drugs & The Role of NITs. Join presenter Dr. Stephen Harrison, a Key Opinion Leader in NASH, to learn about the exciting progress of NASH drugs and non-invasive tests in addressing this emerging health crisis. Key points to be […]

Live Webinar: Redefining the Standard of Care for Assessing Liver Health

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on Redefining the Standard of Care for Assessing Liver Health. Join presenters Dr. Tim Salcudean and Dr. Robert Rohling, leading experts and inventors in medical ultrasound imaging, to learn about: The Power of 3D Elastography in Measuring Liver Fibrosis How and Why Ultrasound […]

Visit VelacurTM at NASH-TAG 2021

Discover how fast, accurate and easy VelacurTM is to assess liver health at the NASH-TAG Conference, March 11-13, 2021. Read our poster and visit our in-person booth for live demos of Velacur, the first handheld 3D liver health assessment solution. Developed by Sonic Incytes Medical Corp., VelacurTM is a breakthrough, point of care ultrasound solution that […]

Live Webinar: The Role of Next-Gen NITs in NAFLD/NASH

Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Role of Next-Gen Non-Invasive Tests (NITs) in NAFLD/NASH. Join presenter Dr. Robert Gish, a renowned hepatologist and gastroenterologist, to learn about: Non-Invasive Tests (NITs) for Detecting NAFLD/NASH Role of NITs in Staging Fibrosis & Quantifying Steatosis Best Practices for Integrating NITs […]

Sonic Incytes Introduces VelacurTM at 2021 Digital Medicine & Medtech Showcase

Sonic Incytes Medical Corp. is pleased to present its breakthrough liver health assessment solution, VelacurTM, at the Digital Medicine & Medtech Showcase 2021, part of Biotech Showcase™ 2021 and during the 39th Annual JP Morgan Healthcare Conference, taking place the second week of January. Affecting 100 million Americans by 2030, and millions more around the […]

Register for Elastography Webinar Series

During The Liver Meeting Digital Experience™ 2020, Sonic Incytes Medical Corp. invites you to a professional development webinar series starting November 15: The Latest Advances in Elastography and its Potential in NAFLD and NASH. Join presenters Dr. Rohit Loomba (University of California, San Diego), Dr. Michael Curry (Beth Israel Deaconess Medical Center, Boston) and Moderator […]

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.